Betta Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate
Betta Pharmaceuticals Co Ltd cash flow reinvestment rate. Betta Pharmaceuticals Co Ltd (300558) has a Cash Flow Reinvestment Rate of 0.40x as of September 2025, reinvesting CN¥90.43 Million (capex CN¥90.43 Million ) from operating cash flow of CN¥224.45 Million. See Betta Pharmaceuticals Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Betta Pharmaceuticals Co Ltd (2011–2025)
Cash flow reinvestment rate of Betta Pharmaceuticals Co Ltd from 2011 to 2025. Historical reinvestment intensity for Betta Pharmaceuticals Co Ltd across 15 annual periods. Explore Betta Pharmaceuticals Co Ltd (300558) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Betta Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate by Year (2011–2025)
Betta Pharmaceuticals Co Ltd cash flow reinvestment rate by year from 2011 to 2025. Year-by-year capital reinvestment analysis for Betta Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Betta Pharmaceuticals Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.02x | CN¥927.94 Million | CN¥911.26 Million | CN¥616.68 Million | ▼ -7.4% |
| 2024 | 1.10x | CN¥1.00 Billion | CN¥911.17 Million | CN¥827.59 Million | ▼ -61.4% |
| 2023 | 2.85x | CN¥2.60 Billion | CN¥914.23 Million | CN¥1.10 Billion | ▼ -62.6% |
| 2022 | 7.61x | CN¥2.33 Billion | CN¥306.74 Million | CN¥1.01 Billion | ▲ +406.1% |
| 2021 | 1.50x | CN¥792.00 Million | CN¥526.63 Million | CN¥758.38 Million | ▼ -4.3% |
| 2020 | 1.57x | CN¥1.01 Billion | CN¥646.02 Million | CN¥685.84 Million | ▲ +33.7% |
| 2019 | 1.17x | CN¥651.97 Million | CN¥555.07 Million | CN¥620.42 Million | ▼ -47.0% |
| 2018 | 2.21x | CN¥634.15 Million | CN¥286.40 Million | CN¥614.83 Million | ▼ -56.9% |
| 2017 | 5.14x | CN¥1.43 Billion | CN¥278.26 Million | CN¥585.78 Million | ▲ +56.6% |
| 2016 | 3.28x | CN¥1.34 Billion | CN¥407.05 Million | CN¥294.50 Million | ▲ +201.1% |
| 2015 | 1.09x | CN¥420.17 Million | CN¥385.56 Million | CN¥133.60 Million | ▲ +78.2% |
| 2014 | 0.61x | CN¥169.73 Million | CN¥277.55 Million | CN¥169.73 Million | ▲ +408.2% |
| 2013 | 0.12x | CN¥22.90 Million | CN¥190.34 Million | CN¥22.90 Million | ▼ -54.0% |
| 2012 | 0.26x | CN¥39.05 Million | CN¥149.29 Million | CN¥39.05 Million | ▼ -82.1% |
| 2011 | 1.46x | CN¥50.81 Million | CN¥34.80 Million | CN¥50.81 Million | — |